查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
睡眠呼吸暂停植入物市场——增长、趋势、COVID-19 影响和预测 (2023-2028)
市场调查报告书
商品编码
1273462

睡眠呼吸暂停植入物市场——增长、趋势、COVID-19 影响和预测 (2023-2028)

Sleep Apnea Implant Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，睡眠呼吸暂停植入物市场预计将以 10.5% 的复合年增长率增长。

COVID-19 对睡眠呼吸暂停植入物市场产生了重大影响，因为睡眠呼吸暂停患者在感染 COVID-19 后症状恶化。 感染加速了呼吸道的炎症，导致睡眠时呼吸更加困难。 此类重大生活事件可能会干扰睡眠并影响市场增长。 例如，2022 年 2 月发表在 ERJ 上的一篇文章发现，睡眠呼吸暂停的患病率和严重程度在疾病恢復过程中增加，这表明 SARS-CoV-2 感染与 SARS-CoV-2 感染之间存在显着相关性 然而，随着限制的解除和 COVID-19 病例的减少，对睡眠呼吸暂停植入物的需求增加、技术的快速进步和睡眠障碍的增加预计将在未来几年推动市场增长。

睡眠呼吸暂停植入物市场的增长可归因于多种因素，例如睡眠障碍的增加和睡眠呼吸暂停植入物的技术进步。 例如，根据 Advisor 2023 更新，美国约有 7000 万人患有睡眠障碍。 此外，研究表明睡眠呼吸暂停植入物的技术进步有望在预测期内促进市场增长。 例如，根据 2022 年 2 月发表在 PubMed 上的一篇论文，微型种植体辅助快速上颚扩大术 (MARPE) 扩大了鼻腔和口腔的尺寸并扩大了中面，降低了气流阻力，从而提高了效果OSA治疗，它已经帮助了一些患者。 此外，2022 年 2 月，LivaNova PLC 将其阻塞性睡眠呼吸暂停 (OSA) 治疗设备植入患者体内，标誌着其首个设备研究豁免研究。 该公司的随机对照试验，使用靶向舌下神经刺激 (OSPREY) 治疗阻塞性睡眠呼吸暂停，评估了 LivaNova aura6000 植入式舌下神经刺激器系统治疗中度至重度 OSA 成年患者的安全性和有效性。我正在尝试来证明它有效。

因此，由于睡眠呼吸暂停患者的数量不断增加以及睡眠呼吸暂停植入物的技术进步激增，所研究的市场预计在预测期内会出现增长。 然而，预计睡眠呼吸暂停植入物的高成本将抑制预测期内的市场增长。

睡眠呼吸暂停植入物的市场趋势

预计在预测期内，阻塞性睡眠呼吸暂停综合征将占睡眠呼吸暂停植入物市场的很大份额

阻塞性睡眠呼吸暂停是一种呼吸在睡眠期间不断停止和开始的疾病，会导致打鼾。 这种疾病通常发生在睡眠期间喉咙肌肉间歇性放鬆，阻塞气道时。 越来越多的患者对持续气道正压通气 (CPAP) 设备无效，加上阻塞性睡眠呼吸暂停的患病率上升，导致睡眠呼吸暂停植入物的引入。 例如，根据 2023 年 1 月更新的 UptoDate 文章，基于每小时 5 次或更多事件/事件的全球估计表明，在 30 岁至 69 岁之间，全球有 9.36 亿轻度至重度 OSA 患者和 4.25 亿人全世界患有中度至重度 OSA 的人。 市场上流行的植入式设备包括 AIRLIFT、remedy System 和 Inspire Therapy。 有人指出，睡眠呼吸暂停综合症与肥胖有关。 因此，肥胖病例的增加预计会增加 OSA 病例。 例如，根据 2022 年世界肥胖地图集，预计到 2030 年将有 5.86 亿女性和 4.34 亿男性肥胖。 在肥胖人群中，上呼吸道的脂肪沉积会使气道变窄并减少这些区域的肌肉活动，从而导致缺氧、呼吸暂停，并最终导致睡眠呼吸暂停。 因此，肥胖的增加将增加 OSA 的合併症，因此在预测期内使用植入物治疗睡眠呼吸暂停可能会推动市场增长。

此外，阻塞性睡眠呼吸暂停领域正在进行的临床研究和开发预计将在预测期内增加对研究标记物的需求。 例如，2021 年 6 月，Inspire Medical Systems, Inc. 正在讚助一项临床研究，评估在植入和治疗 Inspire 上呼吸道刺激 (UAS) 系统后认知和表达语言的客观变化。 因此，此类研究证明了各种阻塞性睡眠呼吸暂停植入物的疗效，预计将在预测期内促进市场增长。

因此，由于阻塞性睡眠呼吸暂停病例的增加和阻塞性睡眠呼吸暂停临床研究的激增，预计该市场在预测期内将出现增长。

睡眠呼吸暂停植入物市场-IMG1

预计北美将占很大份额，预计在预测期内也会如此

北美是全球睡眠呼吸暂停植入物市场的主要参与者，原因包括睡眠呼吸暂停综合征患病率上升、意识提高以及睡眠呼吸暂停植入物临床研究激增等因素。预计将分一杯羹。 例如，根据 2022 年 3 月的一篇 PubMed 论文，研究人员进行的一项基于人口的调查发现，13.1% 的 45 岁及以上的加拿大女性（120 万）和 21.9% 的加拿大男性（180 万）处于患儿高风险OSA，而这种风险在中年和老年男性中比女性高 1.2-2 倍。

此外，2021 年 8 月，亚利桑那大学赞助了一项针对 50 岁及以上并被诊断患有中度或重度阻塞性睡眠呼吸暂停的成年人进行呼吸肌力量训练的研究，以改善血压和心率。一项临床研究进行评估其对血管健康的影响。 此类研究提供了利用睡眠呼吸暂停植入物的重要性，并在预测期内推动了市场增长。

此外，许多政府研究机构正积极关注国内睡眠研究的持续发展，这将促进市场拓展。 例如，根据 NIH 2021 年 12 月的更新，2021 年 NIH 睡眠研究计划基于研究人员、公众、NIH 研讨会参与者和项目工作人员的投入所确定的一组研究需求和机会。我'我在这里。 该计划强化了国家睡眠障碍研究中心的宗旨，并概述了建立在睡眠和昼夜节律研究人员近 30 年令人印象深刻的工作基础上的愿景。 五个战略目标、研究重点和技术都展示了睡眠和昼夜节律科学如何增强医学和改善公众健康。 此外，九个关键观点展示了在睡眠和昼夜节律研究的背景下拓宽生物医学领域的潜力。

因此，由于睡眠呼吸暂停综合征病例的增加和睡眠呼吸暂停植入物临床研究的增加，预计北美在预测期内将占据研究市场的很大份额。

睡眠呼吸暂停植入物市场-IMG2

睡眠呼吸暂停植入物行业概览

市场是整合的，由主要参与者组成。 市场参与者越来越关注开发创新产品，这正在推动市场增长。 目前主导市场的公司包括Medtronic、Respicardia Inc.、Inspire Medical Systems、Siesta Medical Inc.、LivaNova PLC 和 LinguaFlex。

其他福利：

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第一章介绍

  • 调查先决条件
  • 本次调查的范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 睡眠呼吸暂停设备的技术进步
    • 增加睡眠障碍的负担
  • 市场製约因素
    • 睡眠呼吸暂停植入物的高成本
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分

  • 按产品类型
    • 舌下神经刺激器
    • 脑神经刺激器
    • 颚种植体
  • 根据指示
    • 阻塞性睡眠呼吸暂停综合征
    • 中枢性睡眠呼吸暂停综合征
  • 最终用户
    • 医院
    • 门诊手术中心
    • 医务室
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东和非洲地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Inspire Medical Systems
    • LinguaFlex
    • LivaNova PLC
    • Medtronic
    • ZOLL Medical Corporation
    • Siesta Medical Inc.
    • Nyxoah SA

第七章市场机会与未来趋势

简介目录
Product Code: 68307

The sleep apnea implant market is expected to register a CAGR of 10.5% during the forecast period.

COVID-19 had a substantial impact on the sleep apnea implant market since patients with sleep apnea experienced worsening symptoms after affecting COVID-19. The infection promoted airway irritation, making sleep breathing more difficult. Such an important life event is likely to interrupt sleep and have an impact on market growth. For instance, as per the article published in February 2022 in ERJ journal, the researchers showed a significant correlation between increased prevalence and severity of sleep apnea during recovery from illness and the severity of SARS-CoV-2 infection. However, as the restrictions are lifted, and COVID-19 cases are reduced, the market is anticipated to witness growth in the coming years due to the increase in demand for sleep apnea implants, rapid technological advancements, and a rise in sleep disorders.

The growth of the sleep apnea implant market can be attributed to factors such as the rise in sleep disorders and technological advancements in sleep apnea implants. For instance, as per the Advisor 2023 update, about 70 million people in the United States suffer from sleep disorders. In addition, research studies demonstrating the technological advancements of sleep apnea implants are anticipated to boost market growth over the forecast period. For instance, as per the article published in February 2022 in PubMed, mini-implant assisted rapid palatal expansion (MARPE), which increased the size of the nasal and oral cavities and widens the midface, which helped in some patients with OSA therapy by reducing airflow resistance. Furthermore, in February 2022, LivaNova PLC marked its first investigational device exemption study, as the patient was implanted with the company's obstructive sleep apnea (OSA) treatment device. The company's randomized controlled study, "Treating Obstructive Sleep Apnea using Targeted Hypoglossal Neurostimulation" (OSPREY), seeks to demonstrate the safety and effectiveness of the LivaNova aura6000 System, an implantable hypoglossal neurostimulator intended to treat adult patients with moderate to severe OSA.

Thus, due to the rise in sleep apnea cases and the surge in technological advancements in sleep apnea implants, the studied market is anticipated to witness growth over the forecast period. However, the high cost of sleep apnea implants is likely to restrain the market growth over the forecast period.

Sleep Apnea Implant Market Trends

Obstructive Sleep Apnea Segment is Expected to Contribute Significant Share in the Sleep Apnea Implant Market Over the Forecast Period

Obstructive sleep apnea is a disorder in which breathing constantly stops and starts during sleep, leading to snoring. This disorder usually happens due to throat muscles intermittently relaxing and blocking the airway during sleep. A growing number of patients who are not cured by continuous positive airway pressure (CPAP) devices, coupled with the increasing prevalence of obstructive sleep apnea, are leading to the adoption of sleep apnea implants. For instance, as per the UptoDate article updated in January 2023, global estimates based on five or more events/episodes each hour imply that between the ages of 30 and 69, there are 936 million people worldwide with mild to severe OSA and 425 million people worldwide with moderate to severe OSA. Some of the popular implantable devices in the market are AIRLIFT, remede System, and Inspire Therapy. Sleep apnea is linked to the body mass index. Thus increase in obesity cases is expected to raise the cases of OSA. For instance, as per the World Obesity Atlas 2022, 586 million women and 434 million men are expected to be obese by 2030. In obese people, fat deposits in the upper respiratory tract narrow the airway; there is a decrease in muscle activity in this region, leading to hypoxic and apneic episodes, ultimately resulting in sleep apnea. Hence, an increase in obesity is likely to raise the complication of OSA and thereby likely to utilize sleep apnea implants, driving the market growth over the forecast period.

Furthermore, clinical studies and development conducted in the field of obstructive sleep apnea are anticipated to boost the demand for the studied marker over the forecast period. For instance, in June 2021, Inspire Medical Systems, Inc. sponsored a clinical study to evaluate objective change in cognition and expressive language after implant and therapy with Inspire Upper Airway Stimulation (UAS) System. Thus, such studies demonstrating the efficacy of different obstructive sleep apnea implants are anticipated to boost market growth over the forecast period.

Hence, due to the rise in obstructive sleep apnea cases and the surge in clinical studies in obstructive sleep apnea, the studied market is anticipated to witness growth over the forecast period.

Sleep Apnea Implant Market - IMG1

North America is Expected to Hold a Significant Share and Expected to do Same Over the Forecast Period

North America is expected to hold a significant market share in the global sleep apnea implant market owing to factors such as the rising prevalence of sleep apnea in the region, increasing awareness, and a surge in clinical studies in sleep apnea implants. For instance, as per the article published in March 2022 in PubMed, the population-based study conducted by the researchers indicated that 13.1% of Canadian women (or 1.2 million) and 21.9% of Canadian men (or 1.8 million) aged above 45 were at high-risk for presenting OSA and that this risk was 1.2- to twofold higher for middle-aged and older men than women.

Furthermore, in August 2021, the University of Arizona sponsored a clinical study to evaluate the effects of respiratory strength training on blood pressure and cardiovascular health in adults who are 50 years of age and older and have been diagnosed with moderate or severe obstructive sleep apnea. Such research studies provide the importance of utilizing sleep apnea implants, which drive the market growth over the forecast period.

Additionally, many government research organizations are actively focused on the continuous development of sleep research across the country, which is likely to augment the market expansion. For instance, as per the December 2021 update by NIH, the 2021 NIH Sleep Research Plan was based on a set of research needs and opportunities identified with input from researchers, public representatives, NIH workshop participants, and programmatic staff. This plan outlines a vision that enhances the purpose of the National Center for Sleep Disorders Research and builds on sleep and circadian researchers' nearly three decades of remarkable achievement. The five strategic goals, research priorities, and techniques all showed how sleep and circadian sciences might enhance medicine and improve public health. Furthermore, the nine crucial prospects showed the potential to widen the biomedical sciences landscape in the context of sleep and circadian research.

Hence, due to the increase in sleep apnea cases and the rise in clinical studies in sleep apnea implants, North America is expected to hold a significant share of the studied market over the forecast period.

Sleep Apnea Implant Market - IMG2

Sleep Apnea Implant Industry Overview

The market is consolidated and consists of major players. The increasing focus of market players for the development of innovative products are driving the growth of the market. Some of the companies which are currently dominating the market are Medtronic, Respicardia Inc., Inspire Medical Systems, Siesta Medical Inc., LivaNova PLC, and LinguaFlex.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Technological Advancements in Sleep Apnea Devices
    • 4.2.2 Rise in Burden of Sleep Disorders
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Sleep Apnea Implants
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Hypoglossal Neurostimulation Devices
    • 5.1.2 Phrenic Nerve Stimulator
    • 5.1.3 Palatal Implants
  • 5.2 By Indication Type
    • 5.2.1 Obstructive Sleep Apnea
    • 5.2.2 Central Sleep Apnea
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Office Based Clinics
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Inspire Medical Systems
    • 6.1.2 LinguaFlex
    • 6.1.3 LivaNova PLC
    • 6.1.4 Medtronic
    • 6.1.5 ZOLL Medical Corporation
    • 6.1.6 Siesta Medical Inc.
    • 6.1.7 Nyxoah SA

7 MARKET OPPORTUNITIES AND FUTURE TRENDS